Need help comparing HC investment banks

^following

Did a coffee chat with someone from MTS years ago, sounded like you can have some say in regards to the vertical you want to focus on (biopharma is historically their best vertical).

Know a few bankers there and one of their partners (ex-BB MD) supposedly was unanimously seen as their biggest rainmaker. Not sure about their recent hires.

I’d say MTS, know several people there and have only heard great things about culture/hours/comp.

Also talked to a VP who used to work for SVB Securities before it went under, he said it was a sweatshop. But that was several years ago and it might be better now after the Leerink re-rebrand idk

MTS for sure 

Leerink recently completely overhauled their M&A team. Their new co-president is one of the co-founders of PJT and they also hired a couple MDs from Guggenheim and Gordan Dyal. They just advised GSK on its acquisition of IDRx, and a few other M&A deals. I imagine they want to climb higher on the M&A LTs. Also they are at the top of the league tables in Biopharma ECM and churn out multiple FOs, PIPEs, ATMs, etc. per month. MTS is strictly M&A and they do a few $1B+ deals a year, I believe. MTS I have heard also has a fantastic culture/comp and Leerink’s has been iffy at times but believe its improving but who knows. If you’re joining Leerink, you may be doing a bit more “building the brand” type work for the M&A side rather than at MTS where they have been mandated a few times on large deals already. Both of them are great choices and good banks within Biopharma.